What is Plethico Pharmaceuticals Ltd. Quarterly Revenue?

Plethico Pharmaceuticals Ltd. Quarterly Revenue Plethico Pharma Mar-2015 Quarterly Revenue is Rs 13 Cr which is growth of -78.9% YoY.

What is Plethico Pharmaceuticals Ltd. Quarterly Net Profit?

Plethico Pharmaceuticals Ltd. Quarterly Net Profit Plethico Pharma Mar-2015 Quarterly Net Profit is Rs -243 Cr which is growth of -2770.3% YoY.

What is Plethico Pharmaceuticals Ltd. Annual Revenue?

Plethico Pharmaceuticals Ltd. Annual Revenue Plethico Pharma Annual Revenue is Rs 137 Cr which is growth of -76.0% YoY.

What is Plethico Pharmaceuticals Ltd. Annual Net Profit?

Plethico Pharmaceuticals Ltd. Annual Net Profit Plethico Pharma Annual Net Profit is Rs -274 Cr which is growth of -3033.4% YoY.

What is Plethico Pharmaceuticals Ltd. Total Shareholders Fund?

Plethico Pharmaceuticals Ltd. Total Shareholders Fund Plethico Pharma Total Shareholders Fund is Rs 259 Cr which is growth of -51.9% YoY.

What is Plethico Pharmaceuticals Ltd. Total Assets?

Plethico Pharmaceuticals Ltd. Total Assets Plethico Pharma Total Assets is Rs 1,531 Cr which is growth of -10.1% YoY.

What is Plethico Pharmaceuticals Ltd. Book Value Per Share?

Plethico Pharmaceuticals Ltd. Book Value Per Share Plethico Pharma Book Value Per Share is 158 Rs which is growth of -1.6% YoY.

What is Plethico Pharmaceuticals Ltd. ROE?

Plethico Pharmaceuticals Ltd. ROE Plethico Pharma ROE is -2% which is growth of 0.2% YoY.

What is Plethico Pharmaceuticals Ltd. Cash From Operating Activity?

Plethico Pharmaceuticals Ltd. Cash From Operating Activity Plethico Pharma Cash From Operating Activity is Rs 42 Cr which is growth of 214.9% YoY.

What is Plethico Pharmaceuticals Ltd. Net Cash Flow?

Plethico Pharmaceuticals Ltd. Net Cash Flow Plethico Pharma Net Cash Flow is Rs -12 Cr which is growth of -719.2% YoY.

Plethico Pharmaceuticals Ltd.

BSE: 532739

Portfolio

Alert

My Notes

Plethico Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Plethico Pharma quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue Plethico Pharma Mar-2015 Quarterly Revenue is Rs 13 Cr which is growth of -78.9% YoY.
NEGATIVE
Quarterly Net Profit Plethico Pharma Mar-2015 Quarterly Net Profit is Rs -243 Cr which is growth of -2770.3% YoY.

Plethico Pharmaceuticals Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Mar '15	Dec '14	Sep '14	Jun '14	Mar '14	Dec '13	Sep '13	Jun '13	Mar '13	Dec '12	Sep '12	Jun '12	Mar '12
TOTAL_SR_Q Total Rev. ⌄	13.2	20.8	50.3	52.4	62.5	76.3	137.3	183.8	165.9	159.8	95.4	164.9	90.8
SR_Q Operating Rev.	13.2	20.7	50.1	52.7	62	76.3	137	183.8	165.8	159.7	95.4	164.9	90.7
OI_Q Other Income	0	0.1	0.2	-0.4	0.5	-0	0.2	0	0.1	0.2	0	0	0
OEXPNS_Q Operating Exp.	16.6	19.5	45.6	49.8	56.7	73	94.9	126.4	152.7	169	91.5	103.6	118.3
OEXPNS_Q Operating Exp.	16.6	19.5	45.6	49.8	56.7	73	94.9	126.4	152.7	169	91.5	103.6	118.3
OP_Q Operating Profit	-3.4	1.1	4.5	2.9	5.3	3.3	42.1	57.4	13	-9.4	3.9	61.2	-27.6
OPMPCT_Q Operating Profit Margin %	-25.76%	5.42%	9.02%	5.53%	8.51%	4.37%	30.74%	31.24%	7.85%	-5.86%	4.06%	37.13%	-30.38%
DEP_Q Depr.	6.7	2	2	2	2.1	2.1	2.1	2.5	1.7	2.2	2.2	2.2	2.2
INT_Q Interest	21.6	11.6	10	11.3	12.1	11	13.7	13.9	12.1	14.7	12.5	12.9	9.8
PBT_Q Profit Before Tax	-351.2	-12.4	-7.2	-10.8	-8.5	-9.7	26.6	43.6	-3.2	-26.1	-10.8	46.1	-2.1
TAX_Q Tax	-107.9				0	-2.9	0.8	2.5		-5	0.5	2	3.3
NP_Q Net Profit	-243.2	-12.4	-7.2	-10.8	-8.5	-6.8	1.6	2.8	2.2	-37.1	9.4	8.6	11.3
EPS_adj_Q EPS Adj. latest	-	-	-	-	-	-	-	-	-	-	-	-	-
NP_TTM Net profit TTM	-273.6	-38.9	-33.3	-24.4	-10.9	-0.3	-30.6	-22.9	-17	-7.9	-2.1	-34.4	-35.3
EPS_TTM Basic EPS TTM	-80.3	-11.4	-9.8	-7.2	-3.2	-0.1	-9	-6.7	-5	-2.3	-0.6	-10.1	-10.4
results_pdf Results PDF

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Plethico Pharma competitor comparison and performance snapshot within industry

Plethico Pharma annual results: revenue, profit, P&L, and margins as of Mar 2015 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Annual Revenue Plethico Pharma Annual Revenue is Rs 137 Cr which is growth of -76.0% YoY.
NEGATIVE
Annual Net Profit Plethico Pharma Annual Net Profit is Rs -274 Cr which is growth of -3033.4% YoY.

Plethico Pharmaceuticals Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '15	Mar '14	Dec '12	Dec '11	Dec '10	Dec '09	Dec '08	Dec '07	Sep '06	Sep '05
SR_A Total Rev. Ann. ⌄	-35.6%	-20.2%	136.6	136.6	568.6	510.8	493.3	423	464.8	535.3	549.2	327	221.6
TotalOperatingRevenues_A Operating Rev. Ann.	-34%	-21.1%	136.6	136.6	531.3	475.1	412	447.5	474.4	474.7	551.7	319.6	222.6
OI_A Other Income Ann.	-22.9%	-			37.3	35.8	81.3	-24.6	-9.5	60.6	-2.6	7.4	-1
OEXPNS_A Operating Exp. Ann.	-35.2%	-16.5%	131.5	131.5	503.7	483	372.3	324.3	340.5	380.3	388.9	228.1	154.1
OEXPNS_A Operating Exp. Ann.	-35.2%	-16.5%	131.5	131.5	503.7	483	372.3	324.3	340.5	380.3	388.9	228.1	154.1
OP_A Operating Profit Ann.	-	-46.9%	5.2	5.2	27.6	-7.9	39.7	123.3	133.9	94.4	162.8	91.5	68.5
OPMPCT_A OPM Ann. %	-	-33.6%		3.77%	4.85%	-1.55%	8.05%	29.14%	28.80%	17.64%	29.65%	27.98%	30.92%
TotalExpenses_A Total Exp. Ann. ⌄	-28.4%	-11.3%		198.6	576.9	541.2	457.7	361.2	375.8	404.7	405.1	238.8	162.1
OtherExpenses_A Other Exp. Ann.	-21.1%	-13%	23.8	23.9	51.6	48.7	75.3	47.9	68.1	60.4	28.3	15.9	12.7
EmployeeBenefitExpenses_A Employee Exp. Ann.	-2.5%	-2.9%	26.8	26.8	33.7	28.9	35.4	31.1	25.8	25.8	24.1	12.8	10.3
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	-42.9%	-44.5%		5.2	64.9	27.9	121	98.7	124.3	155	160.3	98.9	67.5
EBIDTPCT_A EBITDA Ann. margin %	-11.6%	-30.6%		3.77%	11.41%	5.45%	24.53%	23.34%	26.75%	28.95%	29.18%	30.25%	30.46%
INT_A Interest Ann.	2.9%	13%	54.4	54.4	62.8	49.9	77.2	29.5	29.1	17.1	9.4	5.6	3
DEP_A Depr.	15.2%	11.1%	12.7	12.7	10.4	8.3	8.2	7.5	6.2	7.3	6.7	5.2	5
PBT_A PBT Ann.	-	-	-381.5	-381.5	-8.3	7.1	35.6	61.8	89.1	130.6	144.1	88.2	59.5
TAX_A Tax Ann.	-	-	-107.9	-107.9	0.4	0.8	10.2	19.6	0.4	2.8	3	2.2	3.4
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-	-		-273.6	-8.7	6.3	25.4	42.2	88.7	127.7	141.1	86	56.1
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-	-	-273.6	-273.6	-8.7	-7.9	-37.6	57.9	107	60.9	158.3	86	56.1
NETPCT_A NPM Ann. %	-	-		-200.25%	-1.64%	-1.66%	-9.13%	12.93%	22.56%	12.81%	28.69%	26.91%	25.21%
EPS_adj_A EPS Adj. latest Ann.	-	-		-	-	-	-	-	-	-	-	-	-
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

-76%

3Y CAGR

-35.6%

5Y CAGR

-20.2%

7Y CAGR

-17.7%

10Y CAGR

-4.7%

Total Revenue Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

-73.9%

3Y CAGR

-35.2%

5Y CAGR

-16.5%

7Y CAGR

-14.1%

10Y CAGR

-1.6%

Operating Expenses Annual Cr is falling faster than historical averages.

Plethico Pharma balance sheet as of Mar 2015: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Total Shareholders Fund Plethico Pharma Total Shareholders Fund is Rs 259 Cr which is growth of -51.9% YoY.
NEGATIVE
Total Assets Plethico Pharma Total Assets is Rs 1,531 Cr which is growth of -10.1% YoY.

Plethico Pharmaceuticals Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '15	Mar '14	Dec '12	Dec '11	Dec '10	Dec '09	Dec '08	Dec '07	Sep '06	Sep '05
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-22.1%	-18%	259	538.6	547.4	665.1	699.2	678.1	609.6	593.1	443.8	262.3
EQCAP_A Equity Share Capital Ann.	0%	0%	34.1	34.1	34.1	34.1	34.1	34.1	34.1	34.1	34.1	7.6
TotalShareCapital_A Total Share Capital Ann.	0%	0%	34.1	34.1	34.1	34.1	34.1	34.1	34.1	34.1	34.1	7.6
ReservesAndSurplus_A Reserves Plus Surplus Ann.	-24%	-19.5%	225	504.6	513.3	611	665.2	644.1	575.5	559	409.7	254.7
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	-24%	-19.5%	225	504.6	513.3	611	665.2	644.1	575.5	559	409.7	254.7
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	12.9%	-16.3%	229.6	96.7	159.6	182.9	558.3	571.2	590.1	350.4	66.8	43.3
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	2.4%	3.5%		17.2	16.8	16	15.5	14.5	14.3	12	10.1	8
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	21.9%	-	22.8	20.5	12.6	15.3
CL_A Total Current Liabilities Ann. ⌄	1.5%	62.4%	1,042.2	1,068.2	997.3	787.2	92.2	68.7	114.4	74.9	65	47.7
TradePayables_A Trade Payables Ann.	-6.7%	4.4%	18.6	22.4	22.9	18.6	15	19.6	22	14.4	11.6	8.2
OtherCurrentLiabilities_A Other Current Liabilities Ann.	6%	143.7%	826	778.7	694.3	595.3	9.6	6.2	6.1	6.3	5.6	4.5
ShortTermProvisions_A ST Provisions Ann.	1.2%	16.7%	63.3	62.2	61.1	29.1	29.3	10.8	10.5	10	10	2.5
TL_A Total Capital Plus Liabilities Ann.	0%	4.8%	1,703.5	1,703.5	1,704.2	1,635.3	1,349.7	1,318.1	1,314.1	1,018.3	575.6	353.4
FixedAssets_A Fixed Assets Ann. ⌄	-7.9%	-6.4%	100.3	118.6	128.2	132.9	139.3	135.5	130.7	113.4	116.9	98.6
TangibleAssets_A Tangible Assets Ann.	-7.9%	-5.9%	100.3	118.6	128.2	132.9	136.3	105.3	111.3	111	93.3	98.1
IntangibleAssets_A Intangible Assets Ann.	-	-
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-					3.1	30.2	19.3	2.4	23.6	0.4
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-10.2%	-5.8%	678	925.2	934.8	939.4	916.4	877.4	854.6	529.5	261.6	223.7
NonCurrentInvestments_A Non Current Investments Ann.	-15.5%	-8.9%	487	806.6	806.6	806.6	775.6	738.5	718.6	408.9	138.3	125.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-	90.7
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	-					1.5	3.4	5.3	7.2	6.5
CA_A Total Current Assets Ann. ⌄	3.5%	14.5%	852.9	778.3	769.4	695.9	433.4	440.7	459.5	488.7	314	129.7
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	5.4%	17.4%	788.5	699.5	673	596.1	352.9	335.5	343.1	265.9	222.7	112
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-22.7%	-0.7%	12	13.9	26	27.5	12.4	18.4	12.7	151.2	70.3	3.1
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-4%	-4%	42.4	48.3	47.9	49.4	52.1	69	87.8	56.9	6.8	3.6
OtherCurrentAssets_A Other Current Assets Ann.	-	-				0.5
TA_A Total Assets Ann.	-3.5%	2.6%	1,530.9	1,703.5	1,704.2	1,635.3	1,349.7	1,318.1	1,314.1	1,018.3	575.6	353.4
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-	-	152	234.4	224.2	12.7	12.8	6.4	0.4	16.7	0.1
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-	-	29.1	29.1	29.1	29.1	29.1	29.1	29.1	29.1	6.3
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	-	806.6	199	198.9	775.6	738.5	718.2	393.9	138.2	125.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-10.1%

3Y CAGR

-3.5%

5Y CAGR

2.6%

7Y CAGR

2.2%

10Y CAGR

15.8%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

-2.4%

3Y CAGR

1.5%

5Y CAGR

62.4%

7Y CAGR

37.1%

10Y CAGR

36.1%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

-51.9%

3Y CAGR

-22.1%

5Y CAGR

-18%

7Y CAGR

-11.5%

10Y CAGR

-0.1%

Total ShareHolders Funds Annual is falling faster than historical averages.

Plethico Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2015 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Plethico Pharma Book Value Per Share is 158 Rs which is growth of -1.6% YoY.
POSITIVE
ROE Plethico Pharma ROE is -2% which is growth of 0.2% YoY.

Plethico Pharmaceuticals Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '15	Mar '14	Dec '12	Dec '11	Dec '10	Dec '09	Dec '08	Dec '07	Sep '06	Sep '05
BVSH_A BVSH Ann.	-0.5%	-5.1%	158.1	158.1	160.7	195.2	205.3	199.1	178.9	174.1	130.3	345.2
ROA_A RoA Ann. %	-	-	-0.51%	-0.51%	-0.46%	-2.30%	4.29%	8.12%	4.63%	15.54%	14.94%	15.88%
ROE_A ROE Ann. %	-	-	-1.62%	-1.62%	-1.44%	-5.65%	8.28%	15.78%	9.98%	26.69%	19.38%	21.39%
ROCE_A ROCE Ann. %	-	-	-1.37%	-1.37%	-1.11%	-4.43%	4.60%	8.56%	5.07%	16.78%	16.84%	18.36%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-13.7%	-29.8%	3.77%	12.20%	5.86%	29.36%	22.05%	26.21%	32.64%	29.04%	30.95%	30.31%
PBITMargin_A EBIT Ann. Margin %	-	-	-5.54%	10.25%	4.11%	27.36%	20.39%	24.90%	31.10%	27.82%	29.34%	28.09%
PBTMargin_A PBT Ann. Margin %	-	-	-279.25%	-1.56%	1.49%	8.63%	13.81%	18.77%	27.50%	26.11%	27.60%	26.72%
NETPCT_A NPM Ann. %	-	-	-200.25%	-1.64%	-1.66%	-9.13%	12.93%	22.56%	12.81%	28.69%	26.91%	25.21%
ASETTO_A Asset Turnover Ann. %	3.8%	-1.2%	31.2	31.2	27.9	25.2	33.2	36	36.1	54.2	55.5	63
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-4.4%	-31.7%	0.7	0.7	0.8	0.9	4.7	6.4	4	6.5	4.8	2.7
QuickRatio_A Quick Ratio Ann.	-4.4%	-31.1%	0.7	0.7	0.8	0.9	4.5	6.2	3.9	6.3	4.6	2.5
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	-	-	-	-	-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-	-	-				85.30%	92.05%	86.01%	94.63%	90.10%	96.62%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-				87.35%	92.61%	87.86%	94.90%	90.73%	96.89%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-				87.35%	92.61%	87.86%	94.90%	90.73%	96.89%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-32.6%	-25.6%	417.2	385.9	1,364.2	1,472.5	1,824.5	1,859.1	1,052.6	1,790.3	1,155.9
EVPerNetSales_A EV Per Net Sales Ann.	2.2%	-5.4%	3.1	0.7	2.9	3.6	4.1	3.9	2.2	3.2	3.6	-
PBV_A Price To Book Value Adjusted	0%	4.6%	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.05	0.06	0.02
EVPerEBITDA_A EV Per EBITDA Ann.	18.2%	34.3%	80.9	6	49	12.2	18.5	15	6.8	11.2	11.7	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-35.2%	-26.5%	0.6	0.3	2.2	2.9	2.8	2.7	0.9	2.8	3.5	-
RetentionRatios_A Retention Ratio Ann. %	-	-	-				85.29%	92.04%	86.00%	94.62%	90.09%	96.61%
EYield_A Earnings Yield Ann.	-	-	-0.1	-0.1	-0	-0	0.1	0.1	0.2	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	-5.9%	-9%	0.5	0.5	0.6	0.4	0.8	0.9	1.1	0.6	0.2	0.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Current Ratio Ann.

3Y CAGR

-4.4%

5Y CAGR

-31.7%

7Y CAGR

-22%

10Y CAGR

-12.6%

Current Ratio Annual growth is higher than historical averages.

Plethico Pharma cash flow: net, operating, investing, and financing flows as of Mar 2015 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Plethico Pharma Cash From Operating Activity is Rs 42 Cr which is growth of 214.9% YoY.
NEGATIVE
Net Cash Flow Plethico Pharma Net Cash Flow is Rs -12 Cr which is growth of -719.2% YoY.

Plethico Pharmaceuticals Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '15	Mar '14	Dec '12	Dec '11	Dec '10	Dec '09	Dec '08	Dec '07	Sep '06	Sep '05
CFO_A Cash from Operating Act. Ann. ⌄	-	-16.3%	42.3	42.3	-36.8	-118.7	102.7	149.9	58.9	60.5	-23.9	25.5
PBT_A PBT Ann.	-	-	-381.5	-8.3	7.1	35.6	61.8	89.1	130.6	144.1	88.2	59.5
INT_A Interest Ann.	2.9%	13%	54.4	62.8	49.9	77.2	29.5	29.1	17.1	9.4	5.6	3
TAX_A Tax Ann.	-	-	-107.9	0.4	0.8	10.2	19.6	0.4	2.8	3	2.2	3.4
CFI_A Cash from Investing Act. Ann.	-	-	2.7	2.7	-1	-31.4	-48.3	-30.4	-336.5	-255.3	-36.5	-39.3
CFA_A Cash from Financing Act. Ann.	-	-	-57.2	-57.2	36.3	165.2	-60.4	-113.8	139.2	275.8	127.5	13.2
NCF_A Net Cash Flow Ann. ⌄	-	-	-	-12.2	-1.5	15.1	-6	5.7	-138.5	80.9	67.2	-0.6
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-1.9%	7.2%	26	26	27.5	12.4	18.4	12.7	151.2	70.3	3.1	3.7
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-18.8%	2.3%	13.9	13.9	26	27.5	12.4	18.4	12.7	151.2	70.3	3.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

5Y CAGR

-16.3%

7Y CAGR

-4.6%

10Y CAGR

5.2%

Cash from Operating Activity Annual growth is higher than historical averages.

Plethico Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Plethico Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents